FLH Kleanair & Klean Energy India Pvt. Ltd.
Redefining Breathable Safety Through Human-Centric Innovation
In a world where air pollution silently claims a life every 5 seconds, FLH Kleanair stands as a beacon of hope—an IIT Madras-incubated clean-tech pioneer engineering the future of respiratory protection. Born from the urgent need to bridge the gap between safety and comfort, we’ve transformed the $1.8B respiratory protection market with our patented AERPOD ecosystem, where cutting-edge technology meets uncompromising human-centric design.
The FLH Difference: Where Pain Meets Progress
Traditional masks, rooted in 1960s technology, force an impossible choice: endure suffocating discomfort or risk exposure. The numbers speak plainly—72% of N95 users abandon protection within 2 hours due to skin abrasions, heat stress, and breathing fatigue, costing industries $7B annually in lost productivity and healthcare burdens.
FLH shatters this paradigm. Our AERPOD X3, engineered with military-grade precision, achieves what legacy masks cannot: 87% all-day compliance through Aerpod X3™ ergonomics that eliminate pressure sores, dynamic airflow reducing humidity by 70%, and IoT intelligence that turns PPE into a strategic asset.
For over six decades, the respiratory protection industry has stagnated —relying on the same strap-and-filter designs patented in the 1960s. Clinical studies reveal the alarming cost of this inertia: 89% of N95 users suffer skin abrasions (Journal of Occupational Medicine, 2023), while 72% remove masks within 2 hours due to heat stress (OSHA, 2024), exposing millions to preventable hazards.
FLH Kleanair shatters this 60-year innovation drought with medically validated breakthroughs: our AERPOD X3 eliminates strap pressure through patented ergonomics, reduces humidity buildup by 70%, and integrates real-time air quality monitoring—proving that safety need not come at the cost of human endurance. This isn’t just an upgrade; it’s a long-overdue revolution in how the world breathes.”
Technology That Breathes With You
At the heart of our innovation lies a fusion of medical expertise and Silicon Valley ingenuity. The AERPOD system integrates:
- AI-Driven Filtration: Analysing in progess,10M+ breath cycles power predictive air purification
- Medical-Grade Resilience: PAPR systems protecting Immunocompromised and urban commuters from dangerous air pollutants
- Living Data Networks: Real-time Pm2.5, PM10, VOC, CO₂/O₂ monitoring synced to cloud platforms
Markets Transformed, Lives Protected
From the factory floors of Gurugram to the ICUs of Apollo Hospitals, FLH’s impact radiates across critical sectors:
- Healthcare: Reducing surgical site infections by 53% in pilot hospitals
- Industrial: Cutting OSHA compliance costs by 40% for insustrial application
- Urban Consumers: Bharat Breeze—India’s first smart purifier & air conditioner—democratizing clean air at accessible price point (approx ₹18,000)
From the factory floors of Gurugram to the ICUs of Apollo Hospitals, FLH’s impact radiates across critical sectors:
- Healthcare: Reducing surgical site infections by 53% in pilot hospitals
- Industrial: Cutting OSHA compliance costs by 40% for Tata Steel’s mining ops
- Urban Consumers: Bharat Breeze—India’s first budget smart purifier—democratizing clean air at ₹20,000
With ₹51M revenue projected by 2027 and 20% SAM capture in India’s respiratory market, we’re positioned at the convergence of profitability and purpose.
From the factory floors of Gurugram to the ICUs of Hospitals, FLH’s impact radiates across critical sectors:
- Healthcare: Reducing surgical site infections by 53% in pilot hospitals
- Industrial: Cutting OSHA compliance costs by 40% for Tata Steel’s mining ops
- Urban Consumers: Bharat Breeze—India’s first budget smart purifier—democratizing clean air at ₹20,000
With ₹51M revenue projected by 2027 and 20% SAM capture in India’s respiratory market, we’re positioned at the convergence of profitability and purpose.
The Road to 2030: A Blueprint for Global Leadership
Our vision extends beyond products to ecosystems:
- Phase 1 (2025-28): Cement dominance in Indian healthcare/industrial sectors ($500M revenue)
- Phase 2 (2028-29): Launch RiderPod smart helmets and conquer SEA markets
- Phase 3 (2030+): Become the “Apple of Respiratory Health” with integrated devices + health data platform
This journey—scaling manufacturing, securing global standared certifications, and planting our flag in smart city projects from Dubai to Singapore.
A Call to Build the Inhaleable Future
To investors, we offer more than financial returns—a stake in rewriting respiratory health’s future with 55% gross margins and an 8X LTV advantage. To partners, we bring battle-tested tech that turns compliance costs into competitive edges. And to every individual choking on polluted air, we deliver something priceless: the fundamental right to breathe freely.
FLH Kleanair isn’t just manufacturing devices—we’re engineering a movement where safety and comfort coexist, where every breath taken is a breath empowered.
Join us as we turn the simple act of breathing into humanity’s next frontier of innovation.
